iPreg Inc., established in 2018, is a biomedical device manufacturer specializing in reproductive medicine. Utilizing the physiological characteristics of sperm, we have developed an advanced sperm sorting device designed to improve sperm quality, supporting infertility treatments and enhancing pregnancy success rates.

With infertility affecting approximately 15% of the global population, iPreg’s technology represents a significant advancement in assisted reproductive techniques. Our Sperm Sorting Chip can increase the proportion of healthy sperm to 90% within 30 minutes. This efficient, safe, and effective process enhances sperm recovery, optimizing the critical step of sperm selection in in vitro fertilization (IVF), ultimately improving the success rates of assisted reproduction.

Principle

This company’s principal technology leverages the intrinsic physiological states of cells to advance our pioneering cell separation techniques. Utilizing principles from fluid mechanics, microfluidics, rheotaxis, chemotaxis, and thermotaxis, They engineer biochips designed for the antibody-free selection and purification of cells. This methodology replicates natural cellular environments, optimizing both the viability and functionality of the cells.

Application

This technology offers diverse applications across several critical fields. In assisted reproduction, it aids in the selection of motile sperm. In oncology, it is crucial for isolating tumor cells for diagnostic purposes and immune cells for therapeutic applications. Additionally, in regenerative medicine, it supports the selection of stem cells. Our versatile biochip technology is capable of sorting various cell types that exhibit medical potential.

Advantages

This technology stands out due to its safety, rapidity, precision, and its ability to emulate natural biological conditions. These features ensure not only the high purity of isolated cells but also maintain their functional integrity for therapeutic applications and scientific research.